CAR T-cell therapy has revolutionized the treatment of certain blood cancers — including leukemias, lymphomas and multiple myeloma. CAR T-cells are genetically enhanced versions of a patient’s own ...
Dana-Farber Cancer Institute is part of a Comprehensive Cancer Center designated by the National Cancer Institute. It is a major affiliate of Harvard Medical School and is located in the Longwood ...
The Dana-Farber Cancer Institute raised $2.5 billion over a seven-year campaign, completing one of the largest fundraising initiatives entirely focused on cancer Monday. “It has been an honor to ...
BOSTON, September 30, 2024--(BUSINESS WIRE)--Dana-Farber Cancer Institute today announced the completion of one of the largest fundraising campaigns focused entirely on cancer, raising a record $2 ...
The therapy has a high rate of relapse, even in patients who first achieve complete remission. Now, a novel approach is helping to keep patients’ cancer-free for longer.